Hyang-Sook Hoe Selected Research

Hyang-Sook Hoe Research Topics

Disease

32	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 04/2005
10	Neuroinflammatory Diseases 01/2022 - 01/2018
8	Neoplasms (Cancer) 01/2020 - 02/2017
4	Cognitive Dysfunction 07/2022 - 01/2016
4	Gliosis 01/2022 - 03/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 05/2013
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2022 - 10/2019
2	Amyloid Plaque 01/2019 - 12/2009
2	Neoplasm Metastasis (Metastasis) 01/2018 - 09/2017
2	Glioma (Gliomas) 12/2017 - 12/2017
1	Tauopathies 09/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Hypertrophy 01/2021
1	Inflammation (Inflammations) 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2018
1	Osteosarcoma (Osteogenic Sarcoma) 09/2017
1	Lung Neoplasms (Lung Cancer) 02/2017
1	Hypertension (High Blood Pressure) 10/2013
1	Substance-Related Disorders (Drug Abuse) 01/2013
1	Memory Disorders (Memory Loss) 01/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2011
1	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2011
1	Encephalitis (Encephalitis, Rasmussen) 09/2010
1	Edema (Dropsy) 09/2010
1	Chronic Brain Injury 12/2009
1	Neuroblastoma 11/2008

Drug/Important Bio-Agent (IBA)

13	Amyloid (Amyloid Fibrils)IBA 01/2019 - 10/2007
12	Proteins (Proteins, Gene)FDA Link 07/2022 - 04/2005
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
6	Amyloid beta-PeptidesIBA 01/2022 - 04/2005
6	Apolipoproteins E (ApoE)IBA 11/2015 - 04/2005
5	ApolipoproteinsIBA 11/2015 - 04/2005
4	CytokinesIBA 01/2022 - 09/2010
3	InflammasomesIBA 01/2022 - 01/2021
3	Phosphotransferases (Kinase)IBA 01/2021 - 03/2010
2	idebenoneIBA 01/2022 - 09/2021
2	Interleukin-6 (Interleukin 6)IBA 09/2021 - 01/2021
2	ibrutinibIBA 01/2021 - 09/2018
2	Dasatinib (BMS 354825)FDA Link 01/2020 - 10/2019
2	Flavin-Adenine Dinucleotide (FAD)IBA 01/2019 - 08/2015
2	ascochlorinIBA 01/2018 - 01/2018
2	Histone Deacetylase InhibitorsIBA 12/2017 - 01/2013
2	Matrix Metalloproteinases (MMPs)IBA 12/2017 - 09/2017
2	CholesterolIBA 06/2012 - 10/2007
1	nilotinib FDA Link 07/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2022
1	Neuroprotective AgentsIBA 01/2022
1	Caspase 1 (ICE Protease)IBA 01/2022
1	Rivastigmine (Exelon)FDA LinkGeneric 09/2021
1	Donepezil (Aricept)FDA LinkGeneric 09/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2021
1	Complement C8 (C8 Complement)IBA 01/2021
1	gliquidoneIBA 01/2021
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Tranylcypromine (Parnate)FDA LinkGeneric 01/2020
1	Monoamine Oxidase (MAO)IBA 01/2020
1	masitinibIBA 01/2020
1	regorafenibIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2018
1	Janus KinasesIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Terpenes (Terpenoids)IBA 01/2018
1	phorbolIBA 12/2017
1	Antineoplastic Agents (Antineoplastics)IBA 12/2017
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2017
1	GlucosinolatesIBA 09/2017
1	phenethyl isothiocyanate (PEITC)IBA 09/2017
1	IsothiocyanatesIBA 09/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017
1	delphinidinIBA 02/2017
1	benzothiazoleIBA 02/2014
1	Ethylene Glycol (Monoethylene Glycol)IBA 02/2014
1	aniline (aniline hydrobromide)IBA 02/2014
1	Antihypertensive Agents (Antihypertensives)IBA 10/2013
1	Valsartan (Vals)FDA Link 10/2013
1	Matrix Metalloproteinase InhibitorsIBA 01/2013
1	Presenilin-1IBA 04/2012
1	CaspasesIBA 06/2011
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2011
1	AntibodiesIBA 09/2010
1	amyloid beta-protein (1-42)IBA 03/2010
1	Protein Isoforms (Isoforms)IBA 12/2009
1	Peptides (Polypeptides)IBA 03/2009
1	tarenflurbilIBA 11/2008
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2008
1	Tissue Inhibitor of Metalloproteinase-3IBA 10/2007
1	Glycogen Synthase Kinase 3 betaIBA 12/2006

Therapy/Procedure

4	Therapeutics 01/2020 - 05/2013